Literature DB >> 26695148

Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.

Ning Qu1,2, Ling Zhang1,2, Zhong-Wu Lu1,2, Qing-Hai Ji3,4, Shu-Wen Yang1,2, Wen-Jun Wei1,2, Yan Zhang1,2.   

Abstract

The influence of predictors for recurrence in relation to recurrence-free survival was analyzed retrospectively in differentiated thyroid cancer (DTC) patients under 21 years of age who underwent primary surgical treatment and who had a pathological diagnosis of DTC between 1983 and 2012 at Fudan University Cancer Hospital. Recurrences were retrospectively analyzed using a Cox regression model for the hazard ratio (HR) according to the clinicopathological features. A meta-analysis was performed with respect to the potential predictors for recurrence from current related studies. In the present study, there were 146 young patients aged from 7 to 20 years, with a female/male ratio of 2.65/1. Female gender was the only factor significantly associated with recurrence according to univariate (HR = 2.812, P = 0.037) and multivariate (HR = 4.107, P = 0.024) Cox regression analyses. Meta-analyses revealed that multifocality (HR = 1.91, P < 0.05) and presentation at diagnosis (HR = 1.39, P < 0.05) were highly associated with recurrence in young DTC patients. However, female gender and other factors, such as age (≤10 vs. 11-20 years), PTC (PTC vs. FTC), extrathyroidal extension, lymph node metastasis, total thyroidectomy (total vs. less than total), radioiodine therapy, and radiation history, were not associated with recurrence in young DTC patients. In conclusion, multifocality and presentation at diagnosis are strong predictive factors of recurrence in relation to recurrence-free survival. We recommend studies with larger sample sizes and longer follow-up to verify the influence of predictors for disease recurrence in young patients.

Entities:  

Keywords:  Differentiated thyroid cancer (DTC); Meta-analysis; Recurrence; Young

Mesh:

Substances:

Year:  2015        PMID: 26695148     DOI: 10.1007/s13277-015-4532-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

1.  Multistate life-tables and regression models.

Authors:  R D Gill
Journal:  Math Popul Stud       Date:  1992       Impact factor: 0.720

Review 2.  Thyroid cancer in children.

Authors:  Catherine Dinauer; Gary L Francis
Journal:  Endocrinol Metab Clin North Am       Date:  2007-09       Impact factor: 4.741

3.  Differentiated thyroid cancer in children and adolescents.

Authors:  D Giuffrida; C Scollo; G Pellegriti; G Lavenia; M P Iurato; V Pezzin; A Belfiore
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

4.  Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.

Authors:  G E Dinse; S W Lagakos
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

5.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.

Authors:  C A Welch Dinauer; R M Tuttle; D K Robie; D R McClellan; R L Svec; C Adair; G L Francis
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

6.  Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children.

Authors:  B Jarzab; D Handkiewicz Junak; J Włoch; B Kalemba; J Roskosz; A Kukulska; Z Puch
Journal:  Eur J Nucl Med       Date:  2000-07

7.  Pediatric thyroid cancer.

Authors:  Devendra A Chaukar; Venkatesh Rangarajan; Narendra Nair; Anil K Dcruz; Mandar S Nadkarni; Prathmesh S Pai; Rajesh C Mistry
Journal:  J Surg Oncol       Date:  2005-11-01       Impact factor: 3.454

8.  Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.

Authors:  A Kundel; G B Thompson; M L Richards; L X Qiu; Y Cai; F W Schwenk; A N Lteif; S T Pittock; S Kumar; P J Tebben; I D Hay; C S Grant
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

9.  Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.

Authors:  Sin-Ming Chow; Stephen C K Law; William M Mendenhall; Siu-Kie Au; Stephen Yau; Oscar Mang; Wai-Hon Lau
Journal:  Pediatr Blood Cancer       Date:  2004-02       Impact factor: 3.167

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  5 in total

1.  Patterns of unmet needs in adolescent and young adult (AYA) cancer survivors: in their own words.

Authors:  Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein
Journal:  J Cancer Surviv       Date:  2017-03-29       Impact factor: 4.442

2.  Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages.

Authors:  Xuhang Zhu; Bin Yu; Yu-Qing Huang; Jing-Nan Zhou; Ming-Hua Ge
Journal:  Int J Endocrinol       Date:  2017-03-03       Impact factor: 3.257

3.  Performance of the American Thyroid Association Risk Classification in a Single Center Cohort of Pediatric Patients with Differentiated Thyroid Cancer: A Retrospective Study.

Authors:  Raad Alwithenani; Sarah DeBrabandere; Irina Rachinsky; S Danielle MacNeil; Mahmoud Badreddine; Stan Van Uum
Journal:  J Thyroid Res       Date:  2019-06-02

4.  Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?

Authors:  Hyungju Kwon; Woosung Lim; Byung-In Moon
Journal:  Cancers (Basel)       Date:  2022-08-26       Impact factor: 6.575

5.  Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

Authors:  Sasha R Howard; Sarah Freeston; Barney Harrison; Louise Izatt; Sonali Natu; Kate Newbold; Sabine Pomplun; Helen A Spoudeas; Sophie Wilne; Tom R Kurzawinski; Mark N Gaze
Journal:  Endocr Relat Cancer       Date:  2022-09-07       Impact factor: 5.900

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.